Health literacy and public health genomics: innovation management by citizens.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 21734432)

Published in Public Health Genomics on July 05, 2011

Authors

Angela Brand, Helmut Brand

Articles by these authors

Health literacy and public health: a systematic review and integration of definitions and models. BMC Public Health (2012) 5.02

Sample, data use and protection in biobanking in Europe: legal issues. Pharmacogenomics (2008) 1.88

Measuring health literacy in populations: illuminating the design and development process of the European Health Literacy Survey Questionnaire (HLS-EU-Q). BMC Public Health (2013) 1.54

Integrative genomics, personal-genome tests and personalized healthcare: the future is being built today. Eur J Hum Genet (2009) 1.47

The impact of genetics and genomics on public health. Eur J Hum Genet (2007) 1.45

An index of barriers for the implementation of personalised medicine and pharmacogenomics in Europe. Public Health Genomics (2014) 1.16

Cross-border health activities in the Euregios: good practice for better health. Health Policy (2008) 1.09

Prevalence and socioeconomic correlates of chronic morbidity among elderly people in Kosovo: a population-based survey. BMC Geriatr (2013) 1.02

The future of technologies for personalised medicine. N Biotechnol (2012) 1.01

Available Tools to Facilitate Early Patient Access to Medicines in the EU and the USA: Analysis of Conditional Approvals and the Implications for Personalized Medicine. Public Health Genomics (2015) 1.01

Socioeconomic conditions of elderly people in Kosovo: a cross-sectional study. BMC Public Health (2012) 0.99

Self-stigma, perceived discrimination and empowerment among people with a mental illness in six countries: Pan European stigma study. Psychiatry Res (2013) 0.96

Status of Emergency Contraceptives in Europe One Year after the European Medicines Agency's Recommendation to Switch Ulipristal Acetate to Non-Prescription Status. Public Health Genomics (2016) 0.94

Public health genomics--public health goes personalized? Eur J Public Health (2011) 0.90

Health inequalities and regional specific scarcity in primary care physicians: ethical issues and criteria. Int J Public Health (2013) 0.90

Getting ready for the future: integration of genomics into public health research, policy and practice in Europe and globally. Community Genet (2006) 0.89

EU directive on patients' rights to cross border healthcare. BMJ (2013) 0.88

Public Health Genomics and personalized healthcare: a pipeline from cell to society. Drug Metabol Drug Interact (2012) 0.88

Impact of genetic notification on smoking cessation: systematic review and pooled-analysis. PLoS One (2012) 0.85

Health technology assessment in the era of personalized health care. Int J Technol Assess Health Care (2011) 0.85

Validity and timeliness of syndromic influenza surveillance during the autumn/winter wave of A (H1N1) influenza 2009: results of emergency medical dispatch, ambulance and emergency department data from three European regions. BMC Public Health (2013) 0.84

Detection and response to a meningococcal disease outbreak following a youth football tournament with teams from four European countries. Int J Hyg Environ Health (2002) 0.83

Communicating genetics and smoking through social media: are we there yet? J Med Internet Res (2013) 0.82

Good governance for the public's health. Eur J Public Health (2007) 0.81

Quality improvement competency gaps in primary care in Albanian, polish and slovenian contexts: a study protocol. Acta Inform Med (2012) 0.81

Translational potential into health care of basic genomic and genetic findings for human immunodeficiency virus, Chlamydia trachomatis, and human papilloma virus. Biomed Res Int (2013) 0.81

Whole genome prediction of bladder cancer risk with the Bayesian LASSO. Genet Epidemiol (2014) 0.80

Health literacy: the essential catalyst for the responsible and effective translation of genome-based information for the benefit of population health. Public Health Genomics (2011) 0.80

Early Patient Access to Medicines: Health Technology Assessment Bodies Need to Catch Up with New Marketing Authorization Methods. Public Health Genomics (2016) 0.80

Ethical evaluation of compulsory measles immunisation as a benchmark for good health management in the European Union. Cent Eur J Public Health (2009) 0.80

The Icelandic ash cloud and other erupting health threats: what role for syndromic surveillance? Eur J Public Health (2010) 0.79

Public health in the genomic era: will Public Health Genomics contribute to major changes in the prevention of common diseases? Arch Public Health (2011) 0.78

Twentieth anniversary of the European Union health mandate: taking stock of perceived achievements, failures and missed opportunities - a qualitative study. BMC Public Health (2013) 0.78

Public health and valorization of genome-based technologies: a new model. J Transl Med (2011) 0.78

Perspectives on Translational Genomics and Public Health in India. Public Health Genomics (2015) 0.77

Austerity policies in Europe-bad for health. BMJ (2013) 0.77

Determinants of witnessed parental physical violence among university students in transitional Albania. J Public Health (Oxf) (2010) 0.77

Establishing the Evidence Bar for Molecular Diagnostics in Personalised Cancer Care. Public Health Genomics (2015) 0.77

Health literacy--a strategic asset for corporate social responsibility in Europe. J Health Commun (2011) 0.76

Genetic similarities between tobacco use disorder and related comorbidities: an exploratory study. BMC Med Genet (2014) 0.76

Host genetic variations in glutathione-S-transferases, superoxide dismutases and catalase genes influence susceptibility to malaria infection in an Indian population. Mol Genet Genomics (2015) 0.76

Methods for the evaluation of hospital cooperation activities (Systematic review protocol). Syst Rev (2012) 0.75

Test Pricing and Reimbursement in Genomic Medicine: Towards a General Strategy. Public Health Genomics (2016) 0.75

Epigenomics, Pharmacoepigenomics, and Personalized Medicine in Cervical Cancer. Public Health Genomics (2017) 0.75

Public Health Genomics joins forces with the Genomic Medicine Alliance. Public Health Genomics (2014) 0.75

Public health ethical perspectives on the values of the European Commission's White Paper "Together for Health". Cent Eur J Public Health (2012) 0.75

Social networks, social participation and self-perceived health among older people in transitional Kosovo. Eur J Public Health (2013) 0.75

Getting Personal: Accelerating Personalised and Precision Medicine Integration into Clinical Cancer Research and Care in Clinical Trials. Public Health Genomics (2015) 0.75

Public health genetics - experiences and challenges. Community Genet (2006) 0.75

The integration of genome-based information for common diseases into health policy and healthcare as a major challenge for Public Health Genomics: the example of the methylenetetrahydrofolate reductase gene in non-cancer diseases. Mutat Res (2008) 0.75

[In Process Citation]. Gesundheitswesen (2015) 0.75

[New genetic tests and their clinical utility for cancer screening]. Ther Umsch (2013) 0.75

[Mail from Maastricht]. Gesundheitswesen (2014) 0.75

A Brief Outline of the Use of New Technologies for Treating Substance Use Disorders in the European Union. Eur Addict Res (2017) 0.75

Supporting decision making in cross-border regions: a health technology assessment tool for hospitals. Int J Technol Assess Health Care (2012) 0.75

From 'public health in Europe' to 'European public health'. Eur J Public Health (2010) 0.75

Using the reference framework for good measles management in practice--a case study from North Rhine-Westphalia. Cent Eur J Public Health (2009) 0.75

["Medical Emergency Services as Seen by Consumers". Health services research by CATI survey of the community]. Med Klin (Munich) (2006) 0.75

The realisation of a European health information system--time to get the politicians involved. Eur J Public Health (2014) 0.75

Knowledge and practices of physicians regarding health status and health care services for older people in transitional Kosovo. Med Arch (2013) 0.75

Clinical Trial Data as Public Goods: Fair Trade and the Virtual Knowledge Bank as a Solution to the Free Rider Problem - A Framework for the Promotion of Innovation by Facilitation of Clinical Trial Data Sharing among Biopharmaceutical Companies in the Era of Omics and Big Data. Public Health Genomics (2016) 0.75